OrbusNeich secured an additional court injunction May 14, preventing Boston Scientific Corp. subsidiaries from selling drug-eluting stents in its Promus line in Germany. The new injunction ruling follows an initial injunction against Boston Scientific’s German distributor subsidiary related to an ongoing patent dispute.
OrbusNeich argues that two of its European patents -- EP 1 341 482 and EP 2 311 412 – are infringed by Boston Scientific’s small vessel, small workhorse and workhorse...